Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Turning Point TherapeuticsOpko HealthTheravance BiopharmaBELLUS HealthRa Pharmaceuticals
SymbolNASDAQ:TPTXNASDAQ:OPKNASDAQ:TBPHOTCMKTS:BLUSFNASDAQ:RARX
Price Information
Current Price$36.29$2.07$16.87$7.51$47.00
52 Week RangeBuyBuyBuyN/AHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/AHold
Consensus Price Target$54.56$4.00$49.33N/A$46.09
% Upside from Price Target50.33% upside93.24% upside192.43% upsideN/A-1.93% downside
Trade Information
Market Cap$1.12 billion$1.27 billion$1.00 billion$1.19 billion$2.19 billion
BetaN/A2.221.641.551.34
Average Volume228,2574,431,048246,13361,933615,278
Sales & Book Value
Annual RevenueN/A$990.30 million$60.37 million$30,000.00$2.50 million
Price / SalesN/A1.2915.8339,833.04883.88
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book ValueN/A$3.06 per share($0.93) per share$0.25 per share$4.92 per share
Price / BookN/A0.68-18.1430.049.55
Profitability
Net IncomeN/A$-153,040,000.00$-215,520,000.00$-7,010,000.00$-64,940,000.00
EPSN/A($0.25)($3.99)N/A($2.06)
Trailing P/E Ratio0.00N/AN/A0.00N/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-26.55%-369.67%-49,910.34%N/A
Return on Equity (ROE)N/A-12.17%N/A-48.37%-45.14%
Return on Assets (ROA)N/A-8.62%-45.43%-45.25%-41.83%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.01%0.13%N/AN/A0.02%
Current Ratio32.35%1.21%3.87%13.87%15.30%
Quick Ratio32.35%1.04%3.87%13.87%15.30%
Ownership Information
Institutional Ownership Percentage58.17%24.54%84.16%N/A91.59%
Insider Ownership PercentageN/A42.25%6.60%24.17%4.30%
Miscellaneous
Employees505,6903631072
Shares Outstanding31.34 million615.60 million56.64 million159.12 million47.02 million
Next Earnings Date11/5/2019 (Estimated)11/8/2019 (Estimated)11/5/2019 (Estimated)11/13/2019 (Estimated)11/6/2019 (Estimated)
OptionableNot OptionableOptionableOptionableNot OptionableOptionable
 Turning Point TherapeuticsOpko HealthTheravance BiopharmaBELLUS HealthRa Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel